This retrospective cohort study assesses the cumulative incidence of pregnancy after cancer and disease-free survival in BRCA carriers diagnosed with invasive b
bioAffinity (BIAF) names Jamie Platt, Ph D to board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
bioAffinity Technologies Appoints Jamie Platt, Ph D , to its Board of Directors tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, today announced the appointment of Jamie.
Patients who underwent plasma ctDNA testing started therapy for advanced NSCLC earlier than those who underwent only tissue biopsy, but "plasma first does not mean plasma only," the authors say.